Back to today’s briefing

Story perspectives

Rising Weight-Loss Drug Costs Pressure Employers to Change Benefits

7/18/2025

24 5

Summary

Story summary

Soaring prices of weight-loss medications are forcing U.S. employers to rethink healthcare benefits, with over half planning to raise employee cost-sharing by 2026. The hefty costs of GLP-1 drugs like Wegovy and Zepbound are straining budgets, prompting companies to seek alternative pharmacy benefit managers for clearer pricing and relief from escalating health expenses.

1 of 1

Story summary

Soaring prices of weight-loss medications are forcing U.S. employers to rethink healthcare benefits, with over half planning to raise employee cost-sharing by 2026. The hefty costs of GLP-1 drugs like Wegovy and Zepbound are straining budgets, prompting companies to seek alternative pharmacy benefit managers for clearer pricing and relief from escalating health expenses.